US Trauma Device Market to Reach $3.9 Billion by 2017

A recent study shows that the medical device will be impacted by a growing elderly population and increased incidences of osteoporosis.

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US trauma device market will grow at a steady pace through 2017. Pricing pressures will limit average selling prices but an increase in the size of the elderly population and the related increase in the incidence of osteoporosis will drive an expansion of procedure volumes. Coupled with the adoption of some premium-priced products, this will lead to an increase in market size to nearly $3.9 billion in 2017.

No votes yet

Johnson & Johnson Seeks Zytiga Marketing Approval

The company is looking for approval of its prostate cancer treatment.

The Food and Drug Administration will conduct a six-month review of Zytiga as a treatment for cancer in patients who have not received chemotherapy. The review means the FDA should finish its review, which began in June, in mid-December.

Your rating: None Average: 4 (1 vote)

Nanomaterials Demand to Reach $5.5 Billion by 2016

Pharmaceuticals, drug packaging and other applications are spurring increased demand for the advanced materials.

World demand for nanomaterials will rise more than two-and-a-half times to $5.5 billion in 2016 driven by a combination of increased market penetration of existing materials and ongoing development of new materials and applications.  Nanotubes, along with other materials such as nanoclays and quantum dots, will grow at the fastest pace, with the energy storage and generation market and the construction market undergoing the most rapid expansions.

No votes yet

Report: Falling European Drug Prices to Drive Down Healthcare Costs

A study from GBI Research outlines drug pricing in five European countries and how regulatory mechanisms could affect the drug and pharmaceutical packaging industries. announces that a new market research report is available in its catalog: Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs.

Your rating: None Average: 5 (1 vote)

Drug Web Sites May Not Be That Helpful

UPI Health News (Business) - Jul. 05, 2010

U.S. researchers describe prescription drug maker Web sites a gray area of discourse and ethics.

Lewis Glinert, professor of linguistics at Dartmouth College in Hanover, N.H., and John Schommer of the University of Minnesota in Minneapolis examined Web sites dedicated to the 100 best-selling prescription drugs.

The researchers found consumers were expected to move in a maze of text and navigation choices and that content was unpredictable -- including difficult to discern mixes of information and promotion.

Syndicate content